STAT April 19, 2024
Ed Silverman

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still taking shape. However, we do foresee several naps in our future, if only to recover from promenading with the official mascots. We also hope to catch up on our reading and hold another listening party with Mrs. Pharmalot. The rotation will likely include this, this, this, this and this. And what about you? This is a fine time to enjoy the great outdoors — a walk in the woods, a stroll along city streets, or a day at the shore may be in order. You could...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Project Optimus: helping or hindering cancer drug development?
Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D
Quest to ramp up AI capabilities with purchase of PathAI’s diagnostic lab
Karius Secures $100M to Expand Non-Invasive Pathogen Blood Test
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold

Share This Article